Market Place
Sourcing Support
Ampio prepares to wind down after final therapeutic dream dies
26 Mar 2024 //
FIERCE BIOTECH
Ampio’s last shot at success fizzles out in preclinical stage
15 Feb 2024 //
FIERCE BIOTECH
Ampio Provides Update on Results from Pre-IND Enabling Studies
14 Feb 2024 //
PR NEWSWIRE
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
31 Oct 2023 //
PR NEWSWIRE
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services
05 Oct 2023 //
PR NEWSWIRE
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
26 Sep 2023 //
PR NEWSWIRE
Ampio Pharmaceuticals Announces Reverse Stock Split
31 Aug 2023 //
PR NEWSWIRE
Ampio Announces Series D Preferred Stock Dividend to its Holders of Common Stock
26 May 2023 //
PR NEWSWIRE
Ampio Pharmaceuticals Issues Letter To Stockholders
17 Jan 2023 //
PR NEWSWIRE
Ampio PharmaRegains Compliance with NYSE American Continued Listing Standards
27 Dec 2022 //
PRNEWSWIRE
Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension
17 Nov 2022 //
PRNEWSWIRE
Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split
08 Nov 2022 //
PRNEWSWIRE
Ampio Pharmaceuticals Issues Letter to Stockholders
04 Oct 2022 //
PRNEWSWIRE
After a series of flops, Ampio lays off staff; Antibody startup nabs deal
03 Aug 2022 //
ENDPTS
Ampio Pharmaceuticals Issues Letter to Stockholders
03 Aug 2022 //
PRNEWSWIRE
Ampio Pharmaceuticals` CEO Mike Martino Issues Letter to Stockholders
02 Jun 2022 //
PRNEWSWIRE
Ampio`s years of troubles come to a head with self investigation
17 May 2022 //
FIERCEBIOTECH
Ampio Independent Committee to Conduct Investigation
16 May 2022 //
PRNEWSWIRE
Ampio Pharmaceuticals Reports First-Quarter Financial Results
16 May 2022 //
PRNEWSWIRE
Ampio tumbles on FDA setback for knee osteoarthritis drug
21 Apr 2022 //
MARKETWATCH
Ampio Pharma to Hold Fourth Quarter 2021 Earnings and Business Update Call
23 Mar 2022 //
PRNEWSWIRE
Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference
09 Mar 2022 //
PRNEWSWIRE
Ampio Pharma Releases Positive Phase 3 Data Analysis for Ampion in OAK
02 Mar 2022 //
PRNEWSWIRE
Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
10 Feb 2022 //
PRNEWSWIRE
AMPIO PHARMA ANNOUNCES PRICING OF $22.5M REGISTERED DIRECT OFFERING
11 Dec 2021 //
PRNEWSWIRE
Ampio Pharmaceuticals CEO passes baton to a new board member; & more
24 Nov 2021 //
ENDPTS
Ampio Announces Shareholder / Business Update Call with its CEO & Chairman
23 Nov 2021 //
PRNEWSWIRE
Ampio Announces Q3 2021 Financial Results and Provides Business Update
10 Nov 2021 //
PRNEWSWIRE
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
13 Oct 2021 //
PRNEWSWIRE
Ampio obtains DCGI approval for Phase II Covid-19 trial of inhaled drug
22 Sep 2021 //
CLINICALTRIALSARENA
Ampio Pharma Receives Approval from the SCGI to Commence AP-019 PhII Study
21 Sep 2021 //
PRNEWSWIRE
Ampio Announces Top-line Results from AP-013 PIII Study of Ampion in OAK
15 Sep 2021 //
PRNEWSWIRE
Ampio Announces New Research Manuscript on Anti-Inflammatory Mode of Action
13 Aug 2021 //
PR NEWSWIRE
Ampio Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting
12 Aug 2021 //
PRNEWSWIRE
Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results
04 Aug 2021 //
PRNEWSWIRE
Ampio Present at the American College of Toxicology 42nd Annual Meeting
29 Jul 2021 //
PRNEWSWIRE
Ampio 14th International Congress on Systemic Lupus Erythematosus 6th IC on CORA
28 Jul 2021 //
PRNEWSWIRE
Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019
26 Jun 2021 //
PR NEWSWIRE
Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program
17 Jun 2021 //
PRNEWSWIRE
Ampio Receives Approval to Expand Enrollment of AP-019 Phase II Study to India
15 Jun 2021 //
PRNEWSWIRE
Ampio to Present at the 2021 International Society for Pharmaceutical Engineers
14 Jun 2021 //
PRNEWSWIRE
Ampio Pharmaceuticals to Present at the 2021 International Society
14 Jun 2021 //
PRNEWSWIRE
Ampio Pharma to Participate in Alliance Global Partners` Virtual Summer Meeting
11 Jun 2021 //
PRNEWSWIRE
Ampio Pharma to Participate in Alliance Global Partners` Virtual Summer Meeting
11 Jun 2021 //
PRNEWSWIRE
Ampio to Present Poster at the (ISAM) 23rd International Congress
21 May 2021 //
PRNEWSWIRE
Ampio Pharma to Present Poster at the International Society for Aerosols
21 May 2021 //
PRNEWSWIRE
Ampio Pharma gets IRB approval to begin phase I study using inhaled Ampion
10 May 2021 //
PHARMABIZ
Ampio Pharmaceuticals Receives Investigational Review Board Approval
10 May 2021 //
PRNEWSWIRE
Ampio’s inhaled drug lowers mortality in Covid-19 trial
27 Apr 2021 //
PHARMACEUTICAL-TECHNOLOGY
Ampio Provides Updates on Clinical Programs for Ampion™
27 Apr 2021 //
PRNEWSWIRE
Ampion™ Reduces All-cause Mortality in COVID-19 Distress by Nearly 80%
27 Apr 2021 //
PRNEWSWIRE
Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects
19 Apr 2021 //
PRNEWSWIRE
Ampio Pharmaceuticals` Study Shows Ampion Inhibits a Key
07 Apr 2021 //
PRNEWSWIRE
AMPIO PHARMACEUTICALS’ STUDY SHOWS AMPION INHIBITS
06 Apr 2021 //
PRESS RELEASE
Ampio Pharmaceuticals to Present at the International Society for (ISAM)
29 Mar 2021 //
PRNEWSWIRE
Ampio reveals preliminary positive results on inhaled Ampion in Covid-19
17 Mar 2021 //
PHARMACEUTICAL-TECHNOLOGY
Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion
16 Mar 2021 //
PRNEWSWIRE
Ampio reveals preliminary positive results on inhaled Ampion in Covid-19
16 Mar 2021 //
PHARMACEUTICAL-TECHNOLOGY
Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference
10 Mar 2021 //
PRNEWSWIRE
Ampio to Present at the H.C. Wainwright Global Life Sciences Conference
03 Mar 2021 //
PRNEWSWIRE
